Accuracy and Precision of a Portable Anticoagulation Monitor in a Clinical Setting
Archives of Internal MedicinePublished 1 March 1992
Stephen A. McCurdy
Citations83
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The monitor differed systematically from the laboratory and was moderately less precise; the magnitude of these effects was not great, however, and accuracy was best at around INR = 3.0, the border between low and high therapeutic ranges.
Abstract
The monitor differed systematically from the laboratory and was moderately less precise. The magnitude of these effects was not great, however, and accuracy was best at around INR = 3.0, the border between low and high therapeutic ranges. The clinic-based monitor is useful for patients requiring frequent surveillance of anticoagulation status.
Keywords
Medicine
The LancetSTATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
47,620 Citations1986J Martin Bland, DouglasG. Altman
An alternative approach, based on graphical techniques and simple calculations, is described, together with the relation between this analysis and the assessment of repeatability.
The LancetPLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION
1,826 Citations1989Palle Petersen, J Godtfredsen +3 more
The incidence of thromboembolic complications and vascular mortality were significantly lower in the warfarin group than in the aspirin and placebo groups, which did not differ significantly.
New England Journal of MedicineThe Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1,535 Citations1990Daniel E. Singer
Long-term low-dose warfarin therapy is highly effective in preventing stroke in patients with non-rheumatic atrial fibrillation, and can be quite safe with careful monitoring.
New England Journal of MedicineThe Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
637 Citations1990Pål Smith, Harald Arnesen +1 more
Long-term therapy with warfarin has an important beneficial effect after myocardial infarction and can be recommended in the treatment of patients who survive the acute phase.
New England Journal of MedicineOral Anticoagulant Drugs
567 Citations1991John A. Oates, Alastair J.J. Wood +1 more
The vitamin K-antagonist drugs were reviewed in the Journal in the early 1970s and their safety has been improved for a number of indications without compromising efficacy, through the use of a lower degree of anticoagulation than formerly in North America.
New England Journal of MedicinePreliminary Report of the Stroke Prevention in Atrial Fibrillation Study
352 Citations1990Stroke Prevention in Atrial Fibrillation Study Group Investigators
Preliminary data indicate that antithrombotic therapy with warfarin or aspirin is effective in the short term in reducing the risk of stroke and systemic embolism in patients with atrial fibrillation due to causes other than rheumatic valvular disease.
Annals of Internal MedicineHome Prothrombin Time Monitoring after the Initiation of Warfarin Therapy
191 Citations1989Richard H. White, Stephen A. McCurdy +3 more
Use of a portable prothrombin time monitor by patients at home is feasible and provides accurate measurements, and patients doing home monitoring achieve superior anticoagulation control compared with those receiving standard antICOagulation clinic care.
CHEST JournalOptimal Therapeutic Range for Oral Anticoagulants
153 Citations1989Jack Hirsh, L. Poller +3 more
New England Journal of MedicineAtrial Fibrillation — Risk Marker for Stroke
130 Citations1990James H. Chesebro, Valentı́n Fuster +1 more
Atrial fibrillation not related to valvular heart disease (nonvalvular atrialfibrillation) is associated with nearly half the arterial emboli presumed to be of cardiac origin.
American Journal of Clinical PathologyA Novel Whole Blood Capillary Technic for Measuring the Prothrombin Time
92 Citations1987Fred V. Lucas, Alexander Duncan +7 more
A recently developed capillary whole blood device that uses fingerstick samples was evaluated and appears to be comparable in accuracy to current reference methods.
Archives of Internal MedicinePatient Self-Management of Oral Anticoagulation Guided by Capillary (Fingerstick) Whole Blood Prothrombin Times
90 Citations1989Jack Ansell
This pilot study suggests that patient self-management of warfarin therapy based on fingerstick prothrombin times is feasible and that this model of anticoagulant care offers the potential for improved care at reduced cost.
Clinical & Laboratory HaematologyDiscrepant INR values: a comparison between Manchester and Thrombotest reagents using capillary and venous samples
18 Citations1989Murray Morrison, Alice Little Caldwell +2 more
Examination of INR values of 128 warfarin patients obtained by four different techniques in common use suggests that patients dosed by reference to Manchester venous INR are liable to receive morewarfarin than those dosing by the other methods.